Art

J-GLOBAL ID：201402257891606160   Reference number：14A0574972

The Blood Glucose Level Increased in Parallel with the Heart Rate Following Cilostazol Administration in Three Diabetic Patients

糖尿病患者3人におけるシロスタゾール投与後に血中グルコースレベルは心拍数と平行して増加した

Author (3)： AOKI Yuji (Dep. of Internal Medicine, National Hospital Organization Matsumoto Medical Center Matsumoto Hospital, JPN) ,  SHIMIZU Mika (Dep. of Pharmacy, National Hospital Organization Matsumoto Medical Center Matsumoto Hospital, JPN) ,  WATANABE Nobuaki (Dep. of Neurosurgery, National Hospital Organization Matsumoto Medical Center Matsumoto Hospital, JPN)
Material： Internal Medicine (Web)  (Intern Med (Web))
Volume： 53  Issue： 8  Page： 859-863 (J-STAGE)  Publication year： 2014 
JST Material Number： U0033A  ISSN： 1349-7235  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： drug therapy ,...
Semi thesaurus term： *non-insulin-dependent diabetes mellitus ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0574972&from=J-GLOBAL&jstjournalNo=U0033A") }}

JST classification (3)： Metabolic diseases,nutritional diseases in general.  (GD05010J) ,  Clinical application of drugs acting on carbohydrate metabolism  (GW13030B) ,  Poisoning in general  (GD06010Q)

Substance index (5)： Cilostazol ,  Glucose ,  Glimepiride ,  Sitagliptin ,  Clopidogrel

Reference (21)：

• 1. Chi Y-W, Lavie CJ, Milani RV, White CJ. Safety and efficacy of cilostazol in the management of intermittent claudication. Vasc Health Risk Manag 4: 1197-1203, 2008.
• 2. Beebe HG, Dawson DL, Culter BS, et al. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial. Arch Intern Med 159: 2041-2050, 1999.
• 3. Elam MB, Heckman J, Crouse JR, et al. Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication. Arterioscler Thromb Vasc Biol 18: 1942-1947, 1998.
• 4. Nakaya Y, Minami A, Sakamoto S, et al. Cilostazol, a phosphodiesterase inhibitor, improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty Rat, a model of spontaneous NIDDM. Diabetes Obes Metab 1: 37-41, 1999.
• 5. Park SY, Shin HK, Lee JH, et al. Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription. J Pharmacol Exp Ther 329: 571-579, 2009.

Terms in the title (6)： 糖尿病患者 ,  シロスタゾール ,  投与 ,  血中グルコース ,  心拍数 ,  平行